ModivCare (MODV) to Release Earnings on Thursday

ModivCare (NASDAQ:MODV) is expected to be posting its quarterly earnings results before the market opens on Thursday, February 27th. Analysts expect ModivCare to post earnings of $0.84 per share and revenue of $703.30 million for the quarter. Individual that wish to listen to the company’s earnings conference call can do so using this link.

ModivCare Stock Performance

Shares of NASDAQ MODV opened at $5.75 on Thursday. The company has a market cap of $82.17 million, a PE ratio of -0.45, a price-to-earnings-growth ratio of 3.69 and a beta of 0.55. ModivCare has a 12 month low of $3.64 and a 12 month high of $49.14. The company has a debt-to-equity ratio of 103.63, a current ratio of 0.80 and a quick ratio of 0.80. The company has a 50-day simple moving average of $8.45 and a 200-day simple moving average of $15.39.

Insider Buying and Selling

In other ModivCare news, major shareholder Q Global Capital Management, L purchased 3,352 shares of ModivCare stock in a transaction on Wednesday, December 4th. The shares were purchased at an average cost of $17.74 per share, with a total value of $59,464.48. Following the completion of the transaction, the insider now directly owns 1,924,985 shares in the company, valued at approximately $34,149,233.90. This represents a 0.17 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, major shareholder Catalyst Fund Lp Ai purchased 187,500 shares of ModivCare stock in a transaction on Monday, February 3rd. The shares were acquired at an average cost of $3.87 per share, for a total transaction of $725,625.00. Following the completion of the transaction, the insider now owns 2,130,000 shares of the company’s stock, valued at $8,243,100. This represents a 9.65 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last three months, insiders have purchased 393,306 shares of company stock valued at $1,786,240. Insiders own 1.20% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on the stock. Barrington Research lowered their price target on shares of ModivCare from $25.00 to $10.00 and set an “outperform” rating for the company in a report on Tuesday, January 14th. Stephens reiterated an “equal weight” rating and set a $17.00 price target (down from $21.00) on shares of ModivCare in a report on Friday, January 10th. Finally, Lake Street Capital decreased their target price on shares of ModivCare from $30.00 to $10.00 and set a “buy” rating on the stock in a research report on Monday, January 13th. Three analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, ModivCare has an average rating of “Hold” and an average price target of $18.20.

ModivCare Company Profile

ModivCare Inc, a technology-enabled healthcare services company, provides a suite of integrated supportive care solutions for public and private payors and their members. The company operates through four segments: Non-Emergency Medical Transportation (NEMT), Personal Care, Remote Patient Monitoring (RPM), and Corporate and Other.